Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

79 trials

NCT06614270
Recruiting
Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases
Not applicable · China · 1 site
Registry update: 29 Dec 2025
NCT06775912
Recruiting
Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases
Early phase 1 · China · 1 site
Registry update: 2 Feb 2026
NCT06794008
Recruiting
BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases
Phase 2 · China · 1 site
Registry update: 2 Apr 2025
2023-508398-10-00
Recruiting
Discontinuation of rituximab compared with rituximab maintenance in ANCA-associated vasculitis – a randomized non-blinded controlled trial (DISRITUX)
Phase 4 · Austria, Germany, Denmark, Ireland, Iceland, Netherlands, Sweden · 18 sites
Registry update: 8 Jul 2026
NCT06685042
Recruiting
Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases
Phase 1/2 · Italy · 1 site
Registry update: 11 Apr 2025
NCT06611696
Recruiting
Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis
Phase 4 · Japan · 22 sites
Registry update: 4 May 2025
NCT06696027
Recruiting
AYLo - AutoimmunitY and Loss of y
Not applicable · Germany · 1 site
Registry update: 10 Apr 2025
NCT06733935
Recruiting
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Phase 1/2 · United States · 12 sites
Registry update: 30 Oct 2026
NCT06379646
Recruiting
An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease
Not applicable · China · 1 site
Registry update: 22 Oct 2026
NCT06548607
Recruiting
Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases
Early phase 1 · China · 1 site
Registry update: 6 Mar 2026
NCT06581562
Recruiting
Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.
Phase 1 · United States · 1 site
Registry update: 3 Sept 2024
NCT06308978
Recruiting
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Phase 1 · France, United Kingdom, Sweden, United States · 21 sites
Registry update: 22 May 2026
NCT06285279
Recruiting
The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases
Phase 1 · China · 1 site
Registry update: 6 Jul 2026
NCT07664709
Recruiting
Ocular Manifestations of Granulomatosis With Polyangiitis.
Not applicable · Poland · 1 site
Registry update: 24 Jun 2026
NCT06298448
Recruiting
eGPA and Local Inflammation Within the Ear, Nose and Throat Area
Not applicable · Netherlands · 1 site
Registry update: 7 Mar 2024
2023-508029-28-00
Recruiting
eGPA and local inflammation within the ENT area
Phase 4 · Netherlands · 1 site
Registry update: 2 Feb 2024
NCT06072482
Recruiting
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Phase 4 · Czechia, Denmark, Greece, Hungary, Poland, Romania, United States · 83 sites
Registry update: 30 Sept 2026
NCT06277427
Recruiting
Refractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting CAR-T Cells
Not applicable · China · 1 site
Registry update: 26 Feb 2024
NCT06462768
Recruiting
Neutrophil Extracellular Traps in Different Forms of Systemic Sclerosis
Not applicable · France · 1 site
Registry update: 17 Jun 2024
NCT05979051
Recruiting
A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis （EGPA）
Phase 2/3 · China · 2 sites
Registry update: 4 Dec 2025

Ordered by registry start date. Freshness and sponsorship never change the order.